1. Home
  2. INTR vs FOLD Comparison

INTR vs FOLD Comparison

Compare INTR & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTR
  • FOLD
  • Stock Information
  • Founded
  • INTR 1994
  • FOLD 2002
  • Country
  • INTR Brazil
  • FOLD United States
  • Employees
  • INTR N/A
  • FOLD N/A
  • Industry
  • INTR
  • FOLD Biotechnology: Pharmaceutical Preparations
  • Sector
  • INTR
  • FOLD Health Care
  • Exchange
  • INTR Nasdaq
  • FOLD Nasdaq
  • Market Cap
  • INTR 3.0B
  • FOLD 2.9B
  • IPO Year
  • INTR N/A
  • FOLD 2007
  • Fundamental
  • Price
  • INTR $7.42
  • FOLD $5.64
  • Analyst Decision
  • INTR Buy
  • FOLD Buy
  • Analyst Count
  • INTR 3
  • FOLD 10
  • Target Price
  • INTR $5.97
  • FOLD $16.22
  • AVG Volume (30 Days)
  • INTR 1.8M
  • FOLD 4.5M
  • Earning Date
  • INTR 08-06-2025
  • FOLD 08-07-2025
  • Dividend Yield
  • INTR 1.07%
  • FOLD N/A
  • EPS Growth
  • INTR 97.58
  • FOLD N/A
  • EPS
  • INTR 0.40
  • FOLD N/A
  • Revenue
  • INTR $860,720,325.00
  • FOLD $543,141,000.00
  • Revenue This Year
  • INTR $80.32
  • FOLD $19.84
  • Revenue Next Year
  • INTR $17.51
  • FOLD $23.18
  • P/E Ratio
  • INTR $18.79
  • FOLD N/A
  • Revenue Growth
  • INTR 39.90
  • FOLD 28.25
  • 52 Week Low
  • INTR $3.88
  • FOLD $5.62
  • 52 Week High
  • INTR $7.84
  • FOLD $12.65
  • Technical
  • Relative Strength Index (RSI)
  • INTR 60.50
  • FOLD 33.65
  • Support Level
  • INTR $6.99
  • FOLD $6.00
  • Resistance Level
  • INTR $7.30
  • FOLD $6.22
  • Average True Range (ATR)
  • INTR 0.23
  • FOLD 0.19
  • MACD
  • INTR 0.02
  • FOLD -0.01
  • Stochastic Oscillator
  • INTR 79.31
  • FOLD 2.70

About INTR Inter & Co. Inc.

Inter & Co Inc operates as a digital bank. The company's segment includes Banking & Spending; Investments; Insurance Brokerage; and Inter Shop. It generates maximum revenue from the Banking & Spending segment which comprises a wide range of banking products and services, such as checking accounts, cards, deposits, loans and advances, and other services, which are available to the clients by means of Inter's mobile application.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: